Prophylactic EUS-guided gallbladder drainage prevents acute cholecystitis in patients with malignant biliary obstruction and cystic duct orifice involvement: a randomized trial (with video) - 18/02/23
, Roberto Oleas, MD, Miguel Puga-Tejada, MD, Juan Alcivar-Vasquez, MD, Raquel Del Valle, MD, Juan Olmos, MD, Martha Arevalo-Mora, MD, Maria Egas-Izquierdo, MD, Daniela Tabacelia, MD, Jorge Baquerizo-Burgos, MD, Hannah Pitanga-Lukashok, MDAbstract |
Background and aims |
Patients with distal malignant biliary obstruction (MBO) and cystic duct orifice tumoral involvement have an increased risk for the development of acute cholecystitis after self-expandable metallic stent (SEMS) placement. We aimed to determine whether primary EUS-guided gallbladder drainage prevents acute cholecystitis in these patients.
Methods |
This was a single-center, randomized control trial in patients with distal MBO enrolled from July 2018 to July 2020. Patients were randomized into 2 groups: an interventional group treated with conventional ERCP biliary drainage with SEMS placement and subsequent primary EUS-guided gallbladder drainage (EUS-GBD) and a control group treated with conventional biliary drainage alone. The primary outcome of the study was the occurrence of post-treatment acute cholecystitis, assessed for ≤12 months or until death. The secondary outcomes were hospitalization length and median survival time.
Results |
Forty-four patients were included in the study: 22 in each group. Five patients in the control group (22.7%) and none in the intervention group experienced acute cholecystitis. The median hospitalization time was significantly lower in the interventional group than in the control group (2 days vs 1 day, P = .017). There was no difference in the observed median survival rates in the primary EUS-GBD group (2.9 months) and the control group (2.8 months) (P = .580).
Conclusion |
In this single-center study of patients with unresectable MBO and occlusion of the cystic duct orifice, prophylactic EUS-GBD demonstrated a reduced incidence of acute cholecystitis.
Le texte complet de cet article est disponible en PDF.Abbreviations : EUS-GBD, MBO, OCD, SEMS
Plan
| DISCLOSURE: Dr Robles-Medranda is a key opinion leader and consultant for Pentax Medical, Boston Scientific, Steris, Medtronic, Motus, Micro-tech, G-Tech Medical Supply, CREO Medical, mdconsgroup, and EndoSound. All other authors disclosed no financial relationships. |
Vol 97 - N° 3
P. 445-453 - mars 2023 Retour au numéro
Article précédent
- Development and validation of a machine learning–based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study
- Yifei Huang, Jia Li, Tianlei Zheng, Dong Ji, Yu Jun Wong, Hong You, Ye Gu, Musong Li, Lili Zhao, Shuang Li, Shi Geng, Na Yang, Guofeng Chen, Yan Wang, Manoj Kumar, Ankur Jindal, Wei Qin, Zhenhuai Chen, Yongning Xin, Zicheng Jiang, Xiaoling Chi, Jilin Cheng, Mingxin Zhang, Huan Liu, Ming Lu, Li Li, Yong Zhang, Chunwen Pu, Deqiang Ma, Qibin He, Shanhong Tang, Chunyan Wang, Shanghao Liu, Jitao Wang, Yanna Liu, Chuan Liu, Hao Liu, Shiv Kumar Sarin
- Prophylactic EUS-guided gallbladder drainage: Are we doing too much?
- Anthony Yuen Bun Teoh
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?